Clinical Trial Update: Botulinum Toxin to Improve Results in Cleft Lip Repair [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating botulinum toxin to improve scar outcomes after cleft lip repair, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scar

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Scar | Phase 3 | Status: UNKNOWN